Intensity Therapeutics, Inc. (INTS)
3.35
-0.03
(-0.89%)
USD |
NASDAQ |
Oct 16, 16:00
3.27
-0.08
(-2.39%)
After-Hours: 20:00
Intensity Therapeutics Price : 3.35 for Oct. 16, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 3.40 | 3.40 | 3.14 | 3.35 | 32311.00 |
| Oct 15, 2026 | 3.35 | 3.55 | 3.35 | 3.38 | 8348.00 |
| Oct 14, 2026 | 3.56 | 3.58 | 3.293 | 3.42 | 25895.00 |
| Oct 13, 2026 | 3.20 | 4.04 | 3.097 | 3.55 | 123684.0 |
| Oct 12, 2026 | 3.70 | 3.70 | 3.14 | 3.31 | 41994.00 |
| Oct 09, 2026 | 3.75 | 3.75 | 3.550 | 3.63 | 16724.00 |
| Oct 08, 2026 | 3.76 | 3.80 | 3.58 | 3.68 | 19240.00 |
| Oct 07, 2026 | 3.47 | 3.87 | 3.463 | 3.80 | 17444.00 |
| Oct 06, 2026 | 3.34 | 3.67 | 3.34 | 3.55 | 7450.00 |
| Oct 05, 2026 | 3.45 | 3.75 | 3.45 | 3.45 | 28770.00 |
| Oct 02, 2026 | 3.27 | 3.45 | 3.210 | 3.44 | 15440.00 |
| Oct 01, 2026 | 3.36 | 3.563 | 3.21 | 3.21 | 15278.00 |
| Sep 30, 2026 | 3.40 | 3.457 | 3.275 | 3.37 | 21142.00 |
| Sep 29, 2026 | 3.70 | 3.70 | 3.27 | 3.42 | 34270.00 |
| Sep 28, 2026 | 3.90 | 3.90 | 3.63 | 3.65 | 36184.00 |
| Sep 25, 2026 | 4.096 | 4.096 | 3.80 | 3.80 | 8435.00 |
| Sep 24, 2026 | 4.18 | 4.18 | 3.89 | 3.89 | 10590.00 |
| Sep 23, 2026 | 3.98 | 4.10 | 3.98 | 4.10 | 4117.00 |
| Sep 22, 2026 | 4.01 | 4.11 | 3.888 | 4.01 | 14777.00 |
| Sep 21, 2026 | 4.24 | 4.30 | 4.02 | 4.02 | 6531.00 |
| Sep 18, 2026 | 3.79 | 4.29 | 3.79 | 4.11 | 45213.00 |
| Sep 17, 2026 | 3.989 | 3.989 | 3.79 | 3.88 | 8262.00 |
| Sep 16, 2026 | 3.821 | 3.93 | 3.75 | 3.81 | 9507.00 |
| Sep 15, 2026 | 3.95 | 3.98 | 3.81 | 3.81 | 3875.00 |
| Sep 14, 2026 | 3.959 | 4.053 | 3.90 | 3.98 | 37198.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 55.90 |
| Oncolytics Biotech, Inc. | 0.4981 |
| Sangamo Therapeutics, Inc. | 0.1102 |
| Sarepta Therapeutics, Inc. | 17.10 |
| Anixa Biosciences, Inc. | 2.67 |
Price Related Metrics
| Price to Book Value | 1.071 |
| Earnings Yield | -144.2% |
| Market Cap | 9.868M |